PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Convertible Debt (2019)

PRF Technologies' (PRFX) quarterly Convertible Debt came in at $4.4 million in Q4 2019.

Analysis

PRF Technologies (PRFX) Convertible Debt (2019) Analysis & Trends

PRF Technologies (PRFX) has reported Convertible Debt for 1 consecutive years, with $4.4 million the latest figure, recorded in Q4 2019.

  • For the quarter ending Q4 2019, Convertible Debt changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2019 stood at $4.4 million (changed N/A YoY), and the FY2019 full-year result was $4.4 million, up 19.77% from the prior year.
  • Convertible Debt held at $4.4 million in Q4 2019 per PRFX's latest filing.
  • Across five years, Convertible Debt topped out at $4.4 million in Q4 2019 and bottomed at $4.4 million in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn
10 PRF Technologies 622,054.07 -10.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4.42 Mn
API Access

PRF Technologies Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PRFX&period=max&api_key=YOUR_API_KEY